Condition
Familial Pulmonary Fibrosis
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07201922Phase 3RecruitingPrimary
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT03437486RecruitingPrimary
Mechanisms of Familial Pulmonary Fibrosis
NCT07251725RecruitingPrimary
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
NCT06521125Not Yet RecruitingPrimary
Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis
NCT01088217Unknown
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Showing all 5 trials